Key Clinical Message:
A second wave of dyspnea and desaturation is being observed post
COVID-19 pneumonia and ARDS. It may be secondary to an ongoing lung
inflammation or fibrosis after COVID-19 infection. Steroids may have a
role in the management of the inflammation.